Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

COVID-19 infection may trigger alopecia areata in some patients.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Trichoscopy is good for telling apart tinea capitis and alopecia areata in kids.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Alopecia areata involves immune response and gene changes affecting hair loss.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The superficial temporal artery flap is a reliable method for reconstructing complex facial defects with minimal complications.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Dupilumab for skin problems might reactivate hair loss in some patients.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

Microneedling with triamcinolone helps hair regrowth in ophiasis alopecia areata.